v3.26.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Reconciliation of Financial Measures of Segments to Consolidated Totals
The following are reconciliations of financial measures of the Company’s segments to the consolidated totals:
Three Months Ended March 31, 2026
In millionsHealth Care
Benefits
Health
Services (1)
Pharmacy &
Consumer
Wellness
Corporate/
Other
Consolidated
Totals
Revenues from external customers$35,477 $42,609 $21,752 $14 $99,852 
Intersegment revenues32 5,628 10,237 — 15,897 
Net investment income
462 — — 112 574 
Total revenues35,971 48,237 31,989 126 116,323 
Intersegment eliminations (2)
(15,897)
Total consolidated revenues$100,426 
Less: Net realized capital gains (losses)
— — (17)
Cost of products sold— 44,719 25,790 — 
Health care costs28,579 1,302 — 46 
Operating expenses, excluding other segment items (3)
4,350 727 5,002 674 
Adjusted operating income (loss)$3,041 $1,489 $1,197 $(577)$5,150 
Reconciliation of principal measure of segment performance to consolidated operating income:
Amortization of intangible assets (4)
442 
Net realized capital losses (5)
16 
Acquisition-related integration costs (6)
12 
Operating income (GAAP measure)
4,680 
Interest expense(774)
Other income32 
Income before income tax provision
$3,938 
Depreciation and amortization$340 $258 $406 $111 $1,115 
Three Months Ended March 31, 2025
In millionsHealth Care
Benefits
Health
Services (1)
Pharmacy &
Consumer
Wellness
Corporate/
Other
Consolidated
Totals
Revenues from external customers$34,405 $38,096 $21,553 $14 $94,068 
Intersegment revenues18 5,352 10,359 — 15,729 
Net investment income
387 14 — 119 520 
Total revenues34,810 43,462 31,912 133 110,317 
Intersegment eliminations (2)
(15,729)
Total consolidated revenues$94,588 
Less: Net realized capital gains (losses)
(21)15 — (15)
Cost of products sold— 40,115 25,804 — 
Health care costs28,637 1,047 — 46 
Operating expenses, excluding other segment items (3)
4,201 682 4,795 432 
Adjusted operating income (loss)$1,993 $1,603 $1,313 $(330)$4,579 
Reconciliation of principal measure of segment performance to consolidated operating income:
Amortization of intangible assets (4)
499 
Net realized capital losses (5)
21 
Acquisition-related integration costs (6)
45 
Legacy litigation charge (7)
387 
Loss on Accountable Care assets (8)
247 
Office real estate optimization charges (9)
Operating income (GAAP measure)3,374 
Interest expense(785)
Other income28 
Income before income tax provision$2,617 
Depreciation and amortization$405 $261 $384 $104 $1,154 
_____________________________________________
(1)Total revenues of the Health Services segment include approximately $3.8 billion and $3.7 billion of retail co-payments for the three months ended March 31, 2026 and 2025, respectively.
(2)Intersegment revenue eliminations relate to intersegment revenue generating activities that occur between the Health Care Benefits segment, the Health Services segment, and/or the Pharmacy & Consumer Wellness segment.
(3)Other segment items for each reportable segment consist of the impact of amortization of intangible assets and other items, if any, that neither relate to the ordinary course of the Company’s business nor reflect the Company’s underlying business performance.
(4)The Company’s acquisition activities have resulted in the recognition of intangible assets as required under the acquisition method of accounting which consist primarily of trademarks, customer contracts/relationships, covenants not to compete, technology, provider networks and value of business acquired. Definite-lived intangible assets are amortized over their estimated useful lives and are tested for impairment when events indicate that the carrying value may not be recoverable. The amortization of intangible assets is reflected in operating expenses within each segment. Although intangible assets contribute to the Company’s revenue generation, the amortization of intangible assets does not directly relate to the underwriting of the Company’s insurance products, the services performed for the Company’s customers or the sale of the Company’s products or services. Additionally, intangible asset amortization expense typically fluctuates based on the size and timing of the Company’s acquisition activity. Accordingly, the Company believes excluding the amortization of intangible assets enhances the Company’s and investors’ ability to compare the Company’s past financial performance with its current performance and to analyze underlying business performance and trends. Intangible asset amortization excluded from the related non-GAAP financial measure represents the entire amount recorded within the Company’s GAAP financial statements, and the revenue generated by the associated intangible assets has not been excluded from the related non-GAAP financial measure. Intangible asset amortization is excluded from the related non-GAAP financial measure because the amortization, unlike the related revenue, is not affected by operations of any particular period unless an intangible asset becomes impaired or the estimated useful life of an intangible asset is revised.
(5)The Company’s net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of insurance liabilities. Net realized capital gains and losses are reflected in net investment income within each segment. These capital gains and losses are the result of investment decisions, market conditions and other economic developments that are unrelated to the performance of the Company’s business, and the amount and timing of these capital gains and losses do not directly relate to the underwriting of the Company’s insurance products, the services performed for the Company’s customers or the sale of the Company’s products or services. Accordingly, the Company believes excluding net realized capital gains and losses enhances the Company’s and investors’ ability to compare the Company’s past financial performance with its current performance and to analyze underlying business performance and trends.
(6)During the three months ended March 31, 2026 and 2025, the acquisition-related integration costs relate to the acquisitions of Signify Health and Oak Street Health. The acquisition-related integration costs are reflected in operating expenses within the Corporate/Other segment.
(7)During the three months ended March 31, 2025, the Company recorded a legacy litigation charge related to a court decision associated with its past business practices. The legacy litigation charge was reflected in operating expenses within the Pharmacy & Consumer Wellness segment.
(8)During the three months ended March 31, 2025, the loss on the wind down and sale of Accountable Care assets represents the pre-tax loss on the divestiture of the Company’s MSSP operations, as well as costs incurred in connection with the wind down of the Company’s ACO REACH operations. The loss on Accountable Care assets was reflected in operating expenses within the Health Services segment.
(9)During the three months ended March 31, 2025, the office real estate optimization charges primarily relate to the abandonment of leased real estate and the related right-of-use assets and property and equipment in connection with the Company’s evaluation of corporate office real estate space. The office real estate optimization charges were reflected in operating expenses within each segment.